lilly's glp 1 LLY Stock Outlook: Employer Connect and Oral GLP-1 Upside Lilly is selling $12.9 billion
Description
It cannot replace it
Liraglutide inhibits endothelial-to-mesenchymal transition and attenuates neointima formation after endovascular injury in streptozotocin-induced diabetic mice
A meta-analysis found that liraglutide reduced binge frequency by approximately 1.28 fewer episodes per week compared to placebo ( Choudhury et al., Clinical Therapeutics, 2026 )
If you have a prior history of stomach, and/or gallbladder issues, my experience may be helpful for you to read
Safety of glucagon-like peptide-1 receptor agonists: A real-world study based on the US FDA adverse event reporting system database
These medications have caused thyroid tumors in mice and rats
